Pleasanton, CA (PRWEB) March 18, 2014
Sanarus Technologies, today announced the recent appointment of Lee Story as Sanarus’ President and member of the Board of Directors. Mr. Story brings more than 20 years of expertise to his new role having previously served as a former president, COO, CIO/CTO, and General Manager with organizations from startup to $1B, specializing in new program launch and turn-around opportunities. Most recently, Lee was an SVP with Huntsman Gay Global Capital Private Equity driving strategy alignment and operational excellence across the firm's portfolio. Lee holds two BS degrees in Engineering from the University of California, Davis.
“We welcome Lee’s leadership and experience to the Sanarus team”, said BJ Hardman, Chairman of the Board and CEO. In his new role as President, he will be responsible for business plan execution while creating patient awareness and physician adoption in this new growth phase.
"Sanarus has been the leader in the cryoablation of non-cancerous breast lesions for over a decade”, said Story. “I am excited to be part of the new Sanarus as we chart our path towards treatment of malignant breast tumors. We look to invigorate our brand while partnering with physicians and advocacy groups to develop a stronger, clearer path to the minimally-invasive treatment of all breast tumors and, most importantly, giving women a choice."
Additionally, the company announced the appointment of Jim Plewa to Sanarus’ Board of Directors. Jim brings over 30 years experience in global healthcare and technology with expertise in sales, marketing, business development, and finance and holds a BS in Accountancy from the University of Illinois at Urbana-Champaign. "We welcome Jim to the Board of Directors and look forward to working with him to build shareholder value," said Ms. Hardman.
"Sanarus is committed to women's health with a market-leading technology. The Company is positioning itself to take advantage of current and future opportunities and I am excited to be working with the Board and the leadership team to create more value for shareholders,” said Mr. Plewa.
Sanarus Technologies is a privately held medical device company specializing in minimally- invasive solutions with a focus on developing safe and effective products for the treatment of breast disease. The company’s commitment to women’s health serves as the foundation for its goal to broaden the availability of cryotherapy procedures.